J López-Pedret
About
In The Last Decade
J López-Pedret
22 papers receiving 357 citations
Peers
Comparison fields: 5 of 66
- Molecular Biology 121
- Hematology 115
- Epidemiology 98
- Nephrology 70
- Hepatology 70
Countries citing papers authored by J López-Pedret
This map shows the geographic impact of J López-Pedret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J López-Pedret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J López-Pedret more than expected).
Fields of papers citing papers by J López-Pedret
This network shows the impact of papers produced by J López-Pedret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J López-Pedret. The network helps show where J López-Pedret may publish in the future.
Co-authorship network of co-authors of J López-Pedret
This figure shows the co-authorship network connecting the top 25 collaborators of J López-Pedret. A scholar is included among the top collaborators of J López-Pedret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J López-Pedret. J López-Pedret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | [Cytomegalovirus esophagitis in a patient on peritoneal dyalisis]. | 6 |
| 2 | [Uremic media affects hemostatic properties of human endothelial cells in culture and increases the production of von Willebrand factor]. | 5 |
| 3 | 45 | |
| 4 | 35 | |
| 5 | 94 | |
| 6 | [Autonomic dysfunction in chronic hypotension associated with uremia]. | 1 |
| 7 | Platelet activation on hemodialysis: influence of dialysis membranes. | 36 |
| 8 | Cytomegalovirus colitis in chronic renal failure. | 21 |
| 9 | 10 | |
| 10 | 45 | |
| 11 | [Effects of the treatment with human recombinant erythropoietin on primary hemostasis in uremic patients]. | 1 |
| 12 | 9 | |
| 13 | [Prospective study of 75 episodes of sepsis in hemodialysed patients]. | 1 |
| 14 | [Efficacy of calcium carbonate as a phosphorus-chelating agent in hemodialysis patients]. | 1 |
| 15 | 9 | |
| 16 | 3 | |
| 17 | Beta adrenergic modulation of extrarenal potassium disposal in terminal uraemia. | 14 |
| 18 | Plasmapheresis induced recovery from renal failure in mesangiocapillary glomerulonephritis of acute onset. | 2 |
| 19 | 21 | |
| 20 | Postsynaptic adrenergic unresponsiveness in hypotensive haemodialysis patients. | 13 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.